BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23175662)

  • 41. Emergence of a prominent myeloid clone in a ZNF384-rearranged B-cell precursor acute lymphoblastic leukaemia post-corticosteroid pre-phase therapy.
    Kapadia AB; Sreedharanunni S; Muhammed S; Karmakar I; Rana S; Sharma P; Sachdeva MUS; Trehan A
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28513. PubMed ID: 32686312
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
    Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RCSD1-ABL2 fusion resulting from a complex chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia.
    Raca G; Gurbuxani S; Zhang Z; Li Z; Sukhanova M; McNeer J; Stock W
    Leuk Lymphoma; 2015 Apr; 56(4):1145-7. PubMed ID: 25098428
    [No Abstract]   [Full Text] [Related]  

  • 45. NUP214-ABL1 in adult T-ALL: the GMALL study group experience.
    Burmeister T; Gökbuget N; Reinhardt R; Rieder H; Hoelzer D; Schwartz S
    Blood; 2006 Nov; 108(10):3556-9. PubMed ID: 16873673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia.
    Heilmann AM; Schrock AB; He J; Nahas M; Curran K; Shukla N; Cramer S; Draper L; Verma A; Erlich R; Ross J; Stephens P; Miller VA; Ali SM; Verglio JA; Tallman MS; Mughal TI
    Leukemia; 2017 Sep; 31(9):1989-1992. PubMed ID: 28552906
    [No Abstract]   [Full Text] [Related]  

  • 47. Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia.
    Kustanovich AM; Belevtsev MV; Stasevich IV; Savitskaya TV; Jutzkevich RI; Savva NN; Aleinikova OV
    Leukemia; 2006 Jan; 20(1):165-7. PubMed ID: 16307024
    [No Abstract]   [Full Text] [Related]  

  • 48. A Rare Case Report of B-Cell Acute Lymphoblastic Leukemia with EP300::ZNF384 Fusion Gene.
    Wu X; Yang X; Chen Y; Zhang Z; XinhongYang
    Clin Lab; 2024 Jun; 70(6):. PubMed ID: 38868890
    [No Abstract]   [Full Text] [Related]  

  • 49. Thinking outside of ABL1 for resistance to tyrosine kinase inhibitors: a perspective of the SEPT9-ABL1 fusion protein.
    Hu T; Ciccarelli BT
    Leuk Res; 2014 Dec; 38(12):1399-400. PubMed ID: 25449686
    [No Abstract]   [Full Text] [Related]  

  • 50. SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias.
    Biloglav A; Olsson-Arvidsson L; Theander J; Behrendtz M; Castor A; Johansson B
    Genes Chromosomes Cancer; 2020 Sep; 59(9):540-543. PubMed ID: 32306475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amplification of the
    Ray D; Sharma P; Jain A; Sreedharanunni S
    Turk J Haematol; 2023 Aug; 40(3):204-205. PubMed ID: 37649438
    [No Abstract]   [Full Text] [Related]  

  • 52. Complex MLL rearrangement in non-infiltrated bone marrow in an infant with stage II precursor B-lymphoblastic lymphoma.
    Ahlmann M; Meyer C; Marschalek R; Burkhardt B; Koehler G; Klapper W; Juergens H; Rossig C
    Eur J Haematol; 2014 Oct; 93(4):349-53. PubMed ID: 24635731
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Very rare lineage switch from acute myeloid leukemia with BCR-ABL1 to B-lymphoblastic leukemia.
    Li T; Chen H; Zhang Y; Zeng Y; Zheng L
    Ann Hematol; 2021 Jun; 100(6):1635-1636. PubMed ID: 33674940
    [No Abstract]   [Full Text] [Related]  

  • 54. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.
    Deucher AM; Qi Z; Yu J; George TI; Etzell JE
    Am J Clin Pathol; 2015 Apr; 143(4):547-57. PubMed ID: 25780007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.
    Zaliova M; Stuchly J; Winkowska L; Musilova A; Fiser K; Slamova M; Starkova J; Vaskova M; Hrusak O; Sramkova L; Stary J; Zuna J; Trka J
    Haematologica; 2019 Jul; 104(7):1396-1406. PubMed ID: 30630978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse.
    McClure BJ; Heatley SL; Rehn J; Breen J; Sutton R; Hughes TP; Suppiah R; Revesz T; Osborn M; White D; Yeung DT; White DL
    Br J Haematol; 2020 Oct; 191(2):301-304. PubMed ID: 32731299
    [No Abstract]   [Full Text] [Related]  

  • 57. SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines.
    Quentmeier H; Schneider B; Röhrs S; Romani J; Zaborski M; Macleod RA; Drexler HG
    J Hematol Oncol; 2009 Jan; 2():3. PubMed ID: 19166587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A case of B-cell precursor acute lymphoblastic leukemia with IL3-IGH rearrangement revealed by thromboembolism and marked eosinophilia.
    Derrieux C; Freynet N; Frayfer J; Delabesse E; Clappier E; Defasque S; Broutier H; Fouillard L
    Leuk Lymphoma; 2018 Oct; 59(10):2489-2492. PubMed ID: 29424254
    [No Abstract]   [Full Text] [Related]  

  • 59. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
    Roberts KG; Li Y; Payne-Turner D; Harvey RC; Yang YL; Pei D; McCastlain K; Ding L; Lu C; Song G; Ma J; Becksfort J; Rusch M; Chen SC; Easton J; Cheng J; Boggs K; Santiago-Morales N; Iacobucci I; Fulton RS; Wen J; Valentine M; Cheng C; Paugh SW; Devidas M; Chen IM; Reshmi S; Smith A; Hedlund E; Gupta P; Nagahawatte P; Wu G; Chen X; Yergeau D; Vadodaria B; Mulder H; Winick NJ; Larsen EC; Carroll WL; Heerema NA; Carroll AJ; Grayson G; Tasian SK; Moore AS; Keller F; Frei-Jones M; Whitlock JA; Raetz EA; White DL; Hughes TP; Guidry Auvil JM; Smith MA; Marcucci G; Bloomfield CD; Mrózek K; Kohlschmidt J; Stock W; Kornblau SM; Konopleva M; Paietta E; Pui CH; Jeha S; Relling MV; Evans WE; Gerhard DS; Gastier-Foster JM; Mardis E; Wilson RK; Loh ML; Downing JR; Hunger SP; Willman CL; Zhang J; Mullighan CG
    N Engl J Med; 2014 Sep; 371(11):1005-15. PubMed ID: 25207766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transition from EML1-ABL1 to NUP214-ABL1 positivity in a patient with acute T-lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Graux C; Marynen P; Maertens J; Cools J; Vandenberghe P
    Leukemia; 2006 Dec; 20(12):2202-4. PubMed ID: 17024111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.